Sort   by:  
 Page size 
GenomicsNational Eye Institute (NEI) Ocular Hypertension Treatment Study (OHTS)

The Ocular Hypertension Treatment Study (OHTS) is an National Eye Institute-sponsored multi-center, randomized, prospective treatment trial designed to determine whether lowering intraocular pressure (IOP) in individuals with ocular hypertension delays or prevents the development of primary ope...

phs000240.v1.p1 | EGA
UnknownDelaying treatment of ocular hypertension: the ocular hypertension treatment study.
Not available
S-EPMC3966140 | biostudies-literature
ProteomicsEarly proteomic characteristics and changes in eye tissues in a rat model of ocular hypertension
Early proteomic characteristics and changes in three tissues in a rat model of ocular hypertension
ORGANISM(S): Rattus Norvegicus 
2023-02-09 | PXD039972 |
TranscriptomicsAn Investigation of Global Gene Expression Patterns in Glaucoma and Ocular Hypertension Derived Optic Nerve Heads
Purpose: The optic nerve head (ONH) is the likely site of initial damage in the glaucomatous eye. Despite the recognition of elevated intraocular pressure (IOP) as a leading risk factor for the development of glaucoma, ocular hypertension (OHT) eyes displaying consistently elevated IOP do not experi...
ORGANISM(S): Homo sapiens 
2013-09-27 | E-GEOD-45570 | biostudies-arrayexpress
TranscriptomicsDiabetes and hypertension then reversal in a rat model of diabetic nephropathy
Fisher male Cyp1a1mRen2 rats were allocated into three groups of four or eight biological replicates each: control; combined induced diabetes and hypertension; removal of combined treatments. Kidneys were harvested for gene expression microarray analysis on Affymetrix GeneChip Rat Genome 230 2.0 Gen...
ORGANISM(S): Rattus norvegicus 
2013-04-10 | E-MEXP-3739 | biostudies-arrayexpress
GenomicNEI Ocular Hypertension Treatment Study (OHTS)

The Ocular Hypertension Treatment Study (OHTS) is an National Eye Institute-sponsored multi-center, randomized, prospective treatment trial designed to determine whether lowering intraocular pressure (IOP) in individuals with ocular hypertension delays or prevents the development of primary ope...

phs000240 | dbGaP
UnknownCataract Surgery Lowers Intraocular Pressure and Medication Use in the Medication Group of the Ocular Hypertension Treatment Study.
Not available
S-EPMC8761780 | biostudies-literature
TranscriptomicsComparison of gene expression profile of human trabecular meshwork cells induced by triamcinolone with dexamethasone
PURPOSE. Triamcinolone acetonide (TA) and dexamethasone (DEX) are corticosteroids commonly used for ocular inflammation but both can cause ocular hypertension. We investigated the differential gene expression profile of human trabecular meshwork (TM) cells in response to treatment by TA compared to ...
ORGANISM(S): Homo sapiens 
2008-05-01 | E-GEOD-6298 | biostudies-arrayexpress
GenomicsPROX1 loss in adult mouse Schlemm’s canal causes permanent ocular hypertension
PROX1 loss in adult mouse Schlemm’s canal causes permanent ocular hypertension
PRJNA1366877 | ENA
UnknownThirteen-Year Follow-up of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study.
Not available
S-EPMC5658027 | biostudies-literature
Sort   by:  
 Page size